The proinflammatory cytokine tumor necrosis factor (TNF) is central to the pathogenesis ... clinical trials that have assessed the use of TNF inhibitors in patients with AS, and briefly outlines ...

The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.

Opens in a new tab or window Worries that tumor necrosis factor (TNF) inhibitors may exacerbate or even cause lung disease in patients with rheumatoid arthritis (RA) are unfounded, at least for U ...

Targeted drugs for rheumatoid ... inhibitors reported decreases in pain that were an average of 4.0 points greater (95% CI ...

A 17-year-old white male with Crohn's disease who was receiving maintenance infusions of the anti-tumor necrosis factor (TNF ... patients described had rheumatoid arthritis as their underlying ...

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.